These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12218587)

  • 41. Chemotherapy of acute myelocytic leukemia in children.
    Lie SO; Jonmundsson GK; Mellander L; Siimes MA; Yssing M; Gustafsson G
    Ann N Y Acad Sci; 1997 Sep; 824():84-90. PubMed ID: 9382458
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL).
    Linker CA
    Leukemia; 1997 May; 11 Suppl 4():S24-7. PubMed ID: 9179278
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute lymphoblastic leukemia: an historical perspective.
    Seibel NL
    Hematology Am Soc Hematol Educ Program; 2008; ():365. PubMed ID: 19074111
    [No Abstract]   [Full Text] [Related]  

  • 44. [Report on induction efficacy of protocol ALL-2005 and middle term follow-up of 158 cases of childhood acute lymphoblastic leukemia].
    Tang JY; Gu LJ; Xue HL; Chen J; Pan C; Wu WT; Shen SH; Dong L; Zhou M; Ye QD; Jiang H
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):289-93. PubMed ID: 19799121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia.
    Esteban RE; Christianne B; Alvaro A; Demichelis-Gómez R
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):361-367. PubMed ID: 29544762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. II. Clinical picture and prognosis in specific immunological subgroups].
    Kołecki P; Radwańska U
    Pediatr Pol; 1988 Nov; 63(11):698-702. PubMed ID: 3253656
    [No Abstract]   [Full Text] [Related]  

  • 47. Advances in the diagnostic approach to childhood lymphoblastic malignant neoplasms.
    Reddy KS; Perkins SL
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S3-18. PubMed ID: 15690639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?
    Patil S; Coutsouvelis J; Spencer A
    Cancer Treat Rev; 2011 May; 37(3):202-7. PubMed ID: 20822851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
    Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
    [No Abstract]   [Full Text] [Related]  

  • 50. Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.
    Anselmi L; Bertuccio SN; Lonetti A; Prete A; Masetti R; Pession A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytochemically myeloperoxidase positive childhood acute leukemia with lymphoblastic morphology treated as lymphoblastic leukemia.
    Steiner M; Attarbaschi A; Dworzak M; Strobl H; Pickl W; Kornmüller R; Haas O; Gadner H; Mann G;
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):e4-7. PubMed ID: 19935430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Minimal residual disease in childhood acute lymphoblastic leukemia: diagnosis of the 21 century].
    Szczepański T; Sońta-Jakimczyk D; Van Dongen JJ
    Przegl Lek; 2003; 60 Suppl 5():1-4. PubMed ID: 14574999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clofarabine.
    Pui CH; Jeha S
    Nat Rev Drug Discov; 2005 May; Suppl():S12-3. PubMed ID: 15962525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy of adult acute lymphoblastic leukaemia.
    Stryckmans P; Debusscher L
    Baillieres Clin Haematol; 1991 Jan; 4(1):115-30. PubMed ID: 2039854
    [No Abstract]   [Full Text] [Related]  

  • 55. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
    Matsumura T; Kami M; Saito T; Sakamaki H; Hirai H
    Lancet; 1999 Feb; 353(9154):752-3. PubMed ID: 10073540
    [No Abstract]   [Full Text] [Related]  

  • 57. PEG-linked asparaginase marketed.
    Am J Hosp Pharm; 1994 Jun; 51(11):1382. PubMed ID: 7942872
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacogenomics of childhood acute lymphoblastic leukemia.
    Brenner TL; Pui CH; Evan WE
    Curr Opin Mol Ther; 2001 Dec; 3(6):567-78. PubMed ID: 11804271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discontinuing therapy in childhood acute lymphoblastic leukemia treated with a chemoimmunotherapy protocol.
    Komada Y; Azuma E; Yamamoto H; Tanaka S; Shimizu K; Kamiya H; Sakurai M; Izawa T
    Cancer Immunol Immunother; 1989; 29(1):51-6. PubMed ID: 2706640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Induction chemotherapy in childhood acute lymphoblastic leukemia: the association between the intensity of therapy and cure].
    Li CK
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):321-3. PubMed ID: 17697613
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.